These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6145399)

  • 1. Tardive dyskinesia. A discontinuation study.
    Glazer WM; Moore DC; Schooler NR; Brenner LM; Morgenstern H
    Arch Gen Psychiatry; 1984 Jun; 41(6):623-7. PubMed ID: 6145399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive sequelae of tardive dyskinesia.
    DeWolfe AS; Ryan JJ; Wolf ME
    J Nerv Ment Dis; 1988 May; 176(5):270-4. PubMed ID: 2896762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversibility of "permanent" tardive dyskinesia.
    Klawans HL; Tanner CM; Barr A
    Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM; Casey DE; McFarland BH
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent tardive dyskinesia in bipolar patients.
    Mukherjee S; Rosen AM; Caracci G; Shukla S
    Arch Gen Psychiatry; 1986 Apr; 43(4):342-6. PubMed ID: 2869742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.